Litcius/Paper detail

1373MO JUPITER-06: A randomized, double-blind, phase III study of toripalimab versus placebo in combination with first-line chemotherapy for treatment naive advanced or metastatic esophageal squamous cell carcinoma (ESCC)

R-H. Xu, F. Wang, Chengxu Cui, James C. Yao, Y. Zhang, G. Wang, Jing Feng, Shuguang Yang, Yuhong Fan, Jingwen Shi, X. Zhang, Lin Shen, Yulou Shu, Canhui Wang, Tong Dai, Tianqin Mao, L. Chen, Zhikun Guo, B. Liu, Hong Pan

2021Annals of Oncology24 citationsDOI

Topics & Concepts

MedicineChemotherapyInternal medicineOncologyPlaceboEsophageal squamous cell carcinomaDouble blindPhases of clinical researchCarcinomaPathologyAlternative medicineEsophageal Cancer Research and TreatmentLung Cancer Treatments and MutationsGastric Cancer Management and Outcomes